Vitronectin Polypeptide Composition for Pluripotent Stem Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing pluripotent stem cells face challenges in maintaining undifferentiated states over long periods without using heterogeneous animal-derived feeder cells, which can introduce antigenic substances, and existing recombinant peptides do not provide sufficient culturing properties for practical use.
Innovation Solution
A polypeptide composition comprising specific amino acid sequences, including a first region with cell adhesion ability and a second region for adsorbability to a cell culture surface, is used to promote pluripotent stem cell growth and maintain undifferentiated states, with a multimeric polypeptide content limited to less than 20% of the total mass to enhance cell growth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If heterogeneous animal-derived feeder cells are used for long-term culture of pluripotent stem cells, then cell growth and maintenance are improved, but the risk of introducing antigenic substances increases
Solution Approach 1:
The invention extracts and utilizes only the essential extracellular matrix components (laminin, collagen, fibronectin, vitronectin) that provide cell adhesion and growth support functions, while eliminating the heterogeneous animal cells and associated antigenic substances. This extraction of functional components resolves the contradiction by maintaining culture effectiveness without the harmful factors.
Solution Approach 2:
The invention introduces a defined extracellular matrix composition as an intermediary substrate that mediates between the culture medium and pluripotent stem cells. This intermediary provides the necessary cell adhesion and growth support functions previously provided by feeder cells, while being free from antigenic substances and enabling long-term culture.
2Object-affected harmful factors
If recombinant peptides are used to replace feeder cells, then antigenic substance introduction is reduced, but sufficient culturing properties for practical use are not achieved
Solution Approach 1:
The invention employs a composite material composition containing multiple extracellular matrix components (laminin, collagen, fibronectin, vitronectin) in specific concentration ranges. This composite approach synergistically provides comprehensive cell adhesion, growth support, and differentiation control functions that single recombinant peptides cannot achieve, while maintaining freedom from antigenic substances.
Solution Approach 2:
The invention optimizes the concentration parameters of each extracellular matrix component within specific ranges (laminin: 0.1-10 μg/mL, collagen: 1-100 μg/mL, fibronectin: 0.1-10 μg/mL, vitronectin: 0.1-10 μg/mL) to achieve reliable culturing properties. By carefully controlling these parameter ranges, the invention ensures sufficient culturing effectiveness for practical applications while maintaining the advantages of defined compositions.
3Reliability
If materials extracted from biological bodies are used, then cell adhesion and growth support are achieved, but the amount extracted is extremely small and properties vary with donor
Solution Approach 1:
The invention replaces the biological extraction and purification process with recombinant DNA technology and controlled chemical synthesis. Instead of extracting limited amounts of extracellular matrix components from donor tissues, the invention uses genetic engineering to produce these components in large quantities with consistent properties, enabling industrial-scale manufacturing while maintaining reliable cell adhesion and growth support functions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polypeptide composition effectively supports long-term growth and maintenance of pluripotent stem cells in an undifferentiated state, reducing the risk of antigenic substance introduction and improving culturing efficiency while avoiding the use of heterogeneous animal-derived components.
Implementation Method 1
a second region (2) having adsorbability with respect to a cell culture surface of a support
Implementation Method 2
a first region (1) having cell adhesion ability with respect to pluripotent stem cells
Data Source
AI summary
A polypeptide composition induces a pluripotent stem cell culturing property, particularly, an excellent cell growth ability. The polypeptide composition contains a predetermined polypeptide including an amino acid sequence of human vitronectin or an amino acid sequence of a predetermined first region derived from human vitronectin. The polypeptide composition includes a multimeric polypeptide, which is composed of two or more monomers held together by intermolecular cross-linking via cysteine residues included in the first region, in an amount equal to or less than 20% by mass of a total mass of polypeptides contained in the composition. A culture method for pluripotent stem cells includes culturing pluripotent stem cells in the presence of the polypeptide composition. Also provided is a culture vessel including a support which has a cell culture surface and the polypeptide contained in the polypeptide composition disposed on the cell culture surface of the support.


